CergenX has been awarded the prestigious Irish Times Innovation Award in the Life Sciences & Healthcare category, sponsored by Research Ireland.
This award celebrates their innovation in neonatal brain health, particularly with their new, easy-to-use brain-monitoring technology called Wave. The Wave device helps identify newborns in need of extra support or treatment, with the aim of reducing the impact of brain injury on their lives.
Most of the time, when a baby is born everything goes smoothly. But for some babies, complications can lead to brain injury, hard-to-detect seizures and even problems in later life so early intervention is critical.
Wave aims to solve this by using a quick, easy EEG (electroencephalogram) monitoring system that requires only 10 minutes. The data wings its way to the cloud, where it is analysed by CergenX’s AI, and within seconds the results are back, clearly highlighting whether the results showed any abnormal findings, so medical teams can make important decisions quickly.
The Wave technology emerged from research carried out at the INFANT Research Centre at University College Cork, underlining Ireland’s robust contributions to the medtech sector and CergenX CEO Jason Mowles wants to see it benefit babies around the world.
The Irish Times Innovation Awards, now in their 15th year, are one of Ireland’s most celebrated annual events, bringing recognition to pioneering companies and entrepreneurs. This year, the awards continue to honour innovations across diverse fields, including food and agribusiness, manufacturing, IT, sustainability, and emerging technologies such as AI and fintech.
Image: Dr Siobhan Roche, Director, Science for the Economy at Research Ireland, Sean Griffin, CTO, CergenX and Jason Mowles, CEO, CergenX
